# pathway_0083: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/pathway_0083.txt)

**Task:** `pathway`  
**Author key, unchanged:** **B** — Antifungal biosynthesis. .

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | no saved label | no saved label | output error (invalid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MDLTTTSHARVDSGGVPFTSSLNDPTPPKLSASIALPAHLHLLAKAYGIPESHILQLAWALAANEQNARTAQWEHLELDERQAISWVLRHWQDPSVHRYLSPDELRGDKHQIPATVMAVVEEYSLFQTLALTGSETEIGMCFHPSTEQPWLRVIWNPEGMLASSASRLTRALESALHAVFLTPHVKVGDLTLFSIWDHQQILQWNSHYPQATDRLVHELFKDVVDASPQANAVAAWDGELTYRELDRLSSRLSGRLQDEFGVQPETIVVLCFEKSVWAIVAMLAVVKAGGAFLHVDPQHPAVRHQAMVQTTAAKLVLCSARTRSIISASVPECTSLVIDRRAFSVEPDHVQHETLLSSQNLSPRNAAYVVCTSGSTGTPKAIVVEHASLSTSVDAQANAMEISSGSRVLQYAAYTFDVSVGDIFTALTHGACICIPSDWERSHDLAGAINRLNVNQACLTSTVASILSPAEVPGLEKLTLGGEPATRQCVDAWAEQVRLKNVYGPAECTVWCMIQPEVSRHISVSNIGHGIGARAWIVHPEDHDRLMPVGAVGELLIEGPLVARGYLNDSTRTDEVFLSQPPRWLESFGPTPSRSRFYKTGDLARYGPAGALLFEGRKDTQIKLRGQRIELSEIEYRLHRALSDQVATAVELAHPKGSTAPVLAAFITWDQGIDLQNVQNVTLDARQEFEELASRIKAEIEQALPSYMVPALFIPVQTLPLTTSGKLDRKSLRHFCSQCSHEFLKKLDDSSPADAAPKESANPAEENLARLWAQVLERKSESIRRGDNFLSLGGDSLAAMRLVNLAARDLRLTLTVADVFNSPILADQANLLRPLVQTKHIAPFELVTDGDLPIQDLMDSVAKQCGLTSDQVEDVYPCTPYQEEMVRDSLSGTRTQMGQEVIQLASDLDLSRYLSACARVFQRCPILRTRFVEISGKLLQVVIREDISWQRPTSLAAYIEADNQTPPTLGKPLARWALTEDSTHLVLTMHHAIFDGISLGQIFGAIYAVYQSIPLPQVNLTFATFIGKIYRPHHDLPDASKQFWRSYLSPTAGSNDAPLSDVERASRPCANSGTQRLVTFQAGAVKALQQHGLTEATLARAAWACTLARGRQSPDSDVIFGTILTGRNIHLPGVDALAAPALAHTPIRVRMAAAQQEKPAHFLARVQADATAMIPFEHDGMDRIRALDEQVRVACDNMRTLLVIQPIPEGLILDSKSPFPGTMLSGPRVEAREMRHFHWYGLLMECTLLPMDGFFVRMSFDDTLYSPEAAERLLDEYSQTLHELAHGLTVDGSTE

[Multiple Choices]
A. L-threonine from L-aspartate: step 5/5. .
B. Antifungal biosynthesis. .
C. ergot alkaloid biosynthesis. .
D. oxylipin biosynthesis. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry for nonribosomal peptide synthetase ResC, annotated to the antifungal biosynthesis pathway. The historical entry attributes that pathway annotation to experimental evidence from a cited publication, though the primary paper was not independently assessed here.

Citations as saved: [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3), [C5](#evidence-c5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The long sequence is consistent with a large nonribosomal peptide synthetase, supporting a role in fungal secondary metabolism and making the ordinary amino-acid biosynthesis and oxylipin choices less fitting. That general clue does not establish which specific secondary-metabolite pathway it serves.


**Missing item-specific fact**

> The protein-specific annotation that ResC belongs to the restricticin biosynthetic cluster and is assigned to antifungal biosynthesis.


**Reason**

> Distinguishing antifungal biosynthesis from another fungal specialized-metabolite pathway requires knowing this protein's particular cluster or pathway assignment; that information is absent from the supplied input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "B",
  "C"
]
```

> From the sequence and choices alone, a fungal nonribosomal peptide synthetase is compatible with specialized-metabolite biosynthesis, but the input does not distinguish antifungal biosynthesis from ergot alkaloid biosynthesis. The external annotation supports B for this exact sequence.


### Important caveats

- The source annotation is sequence-matched and cites experimental evidence, but the primary publication was not independently reviewed.
- Reviewer-only accession and pathway information were not provided to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The long sequence is consistent with a large nonribosomal peptide synthetase, supporting a role in fungal secondary metabolism and making the ordinary amino-acid biosynthesis and oxylipin choices less fitting. That general clue does not establish which specific secondary-metabolite pathway it serves.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific annotation that ResC belongs to the restricticin biosynthetic cluster and is assigned to antifungal biosynthesis.",
    "reason": "Distinguishing antifungal biosynthesis from another fungal specialized-metabolite pathway requires knowing this protein's particular cluster or pathway assignment; that information is absent from the supplied input."
  },
  "case_id": "pathway_0083",
  "expected_answer_check": {
    "evidence_ids": [
      "H1",
      "H2",
      "H3",
      "C5"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for nonribosomal peptide synthetase ResC, annotated to the antifungal biosynthesis pathway. The historical entry attributes that pathway annotation to experimental evidence from a cited publication, though the primary paper was not independently assessed here."
  },
  "important_caveats": [
    "The source annotation is sequence-matched and cites experimental evidence, but the primary publication was not independently reviewed.",
    "Reviewer-only accession and pathway information were not provided to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "B",
      "C"
    ],
    "reason": "From the sequence and choices alone, a fungal nonribosomal peptide synthetase is compatible with specialized-metabolite biosynthesis, but the input does not distinguish antifungal biosynthesis from ergot alkaloid biosynthesis. The external annotation supports B for this exact sequence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0083",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for nonribosomal peptide synthetase ResC, annotated to the antifungal biosynthesis pathway. The historical entry attributes that pathway annotation to experimental evidence from a cited publication, though the primary paper was not independently assessed here.",
    "evidence_ids": ["H1", "H2", "H3", "C5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The long sequence is consistent with a large nonribosomal peptide synthetase, supporting a role in fungal secondary metabolism and making the ordinary amino-acid biosynthesis and oxylipin choices less fitting. That general clue does not establish which specific secondary-metabolite pathway it serves.",
    "missing_item_specific_fact": "The protein-specific annotation that ResC belongs to the restricticin biosynthetic cluster and is assigned to antifungal biosynthesis.",
    "reason": "Distinguishing antifungal biosynthesis from another fungal specialized-metabolite pathway requires knowing this protein's particular cluster or pathway assignment; that information is absent from the supplied input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["B", "C"],
    "reason": "From the sequence and choices alone, a fungal nonribosomal peptide synthetase is compatible with specialized-metabolite biosynthesis, but the input does not distinguish antifungal biosynthesis from ergot alkaloid biosynthesis. The external annotation supports B for this exact sequence."
  },
  "important_caveats": [
    "The source annotation is sequence-matched and cites experimental evidence, but the primary publication was not independently reviewed.",
    "Reviewer-only accession and pathway information were not provided to the evaluated model."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry P0DXV3 (RESC_ASPSL, Nonribosomal peptide synthetase resC / Restricticin biosynthesis cluster protein C) carries the PATHWAY annotation 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence from PubMed:39105744, a 2024 J. Agric. Food Chem. paper confirming function, catalytic activity, and pathway). The sequence matches exactly (SHA-256 confirmed). The expected answer B is directly and experimentally supported.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H2](#evidence-h2), [C4](#evidence-c4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A knowledgeable model could identify the protein as a nonribosomal peptide synthetase (NRPS) from domain signatures (condensation, adenylation, and thiolation motifs visible in the ~1295-aa sequence), which eliminates options A (threonine synthase) and D (oxylipin/lipoxygenase pathway) since those involve entirely different enzyme classes. However, distinguishing B (Antifungal biosynthesis) from C (ergot alkaloid biosynthesis) requires knowing which specific secondary metabolite this particular NRPS assembles. Both are fungal NRPS-associated pathways, and the sequence does not contain a generalizable signature that uniquely maps to 'antifungal' rather than 'ergot alkaloid' biosynthesis.


**Missing item-specific fact**

> The identity of the compound synthesized by this specific NRPS (restricticin) and its classification as an antifungal agent. This requires either exact sequence-to-database matching (UniProt P0DXV3) or memorization of the restricticin biosynthetic cluster literature (PubMed:39105744). Without this item-specific annotation, the B-vs-C distinction cannot be resolved by general biological reasoning about NRPS enzymes.


**Reason**

> While NRPS identification from domain architecture is feasible, the pathway assignment among plausible fungal secondary-metabolite options (B vs C) depends on knowing the specific biosynthetic product. No general NRPS feature distinguishes antifungal peptide biosynthesis from ergot alkaloid biosynthesis at the sequence level without database lookup.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A and D are clearly eliminable for an NRPS enzyme. Between B and C, the UniProt annotation with experimental evidence definitively assigns 'Antifungal biosynthesis.' Ergot alkaloid biosynthesis involves a different NRPS (EasC) with distinct substrate specificity and is not applicable to this restricticin-cluster protein. Although a model lacking database access might struggle to distinguish B from C, the annotation is unambiguous.


### Important caveats

- The UniProt entry was first released in 2025-02-05 (entry version 1) and the pathway annotation was added with experimental evidence from a 2024 publication. The benchmark construction date relative to this entry's availability is unknown.
- The 'Antifungal biosynthesis' pathway label is a UniProt-curated category; the underlying compound (restricticin) is described in the source paper as having 'phytotoxic activity,' and the antifungal classification comes from the UniProt curation team's pathway assignment.
- The sequence is 1295 aa, consistent with a single-module NRPS (C-A-T architecture), which is a necessary but not sufficient clue for pathway identification.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A knowledgeable model could identify the protein as a nonribosomal peptide synthetase (NRPS) from domain signatures (condensation, adenylation, and thiolation motifs visible in the ~1295-aa sequence), which eliminates options A (threonine synthase) and D (oxylipin/lipoxygenase pathway) since those involve entirely different enzyme classes. However, distinguishing B (Antifungal biosynthesis) from C (ergot alkaloid biosynthesis) requires knowing which specific secondary metabolite this particular NRPS assembles. Both are fungal NRPS-associated pathways, and the sequence does not contain a generalizable signature that uniquely maps to 'antifungal' rather than 'ergot alkaloid' biosynthesis.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The identity of the compound synthesized by this specific NRPS (restricticin) and its classification as an antifungal agent. This requires either exact sequence-to-database matching (UniProt P0DXV3) or memorization of the restricticin biosynthetic cluster literature (PubMed:39105744). Without this item-specific annotation, the B-vs-C distinction cannot be resolved by general biological reasoning about NRPS enzymes.",
    "reason": "While NRPS identification from domain architecture is feasible, the pathway assignment among plausible fungal secondary-metabolite options (B vs C) depends on knowing the specific biosynthetic product. No general NRPS feature distinguishes antifungal peptide biosynthesis from ergot alkaloid biosynthesis at the sequence level without database lookup."
  },
  "case_id": "pathway_0083",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "H2",
      "C4"
    ],
    "judgment": "supported",
    "reason": "UniProt entry P0DXV3 (RESC_ASPSL, Nonribosomal peptide synthetase resC / Restricticin biosynthesis cluster protein C) carries the PATHWAY annotation 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence from PubMed:39105744, a 2024 J. Agric. Food Chem. paper confirming function, catalytic activity, and pathway). The sequence matches exactly (SHA-256 confirmed). The expected answer B is directly and experimentally supported."
  },
  "important_caveats": [
    "The UniProt entry was first released in 2025-02-05 (entry version 1) and the pathway annotation was added with experimental evidence from a 2024 publication. The benchmark construction date relative to this entry's availability is unknown.",
    "The 'Antifungal biosynthesis' pathway label is a UniProt-curated category; the underlying compound (restricticin) is described in the source paper as having 'phytotoxic activity,' and the antifungal classification comes from the UniProt curation team's pathway assignment.",
    "The sequence is 1295 aa, consistent with a single-module NRPS (C-A-T architecture), which is a necessary but not sufficient clue for pathway identification."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and D are clearly eliminable for an NRPS enzyme. Between B and C, the UniProt annotation with experimental evidence definitively assigns 'Antifungal biosynthesis.' Ergot alkaloid biosynthesis involves a different NRPS (EasC) with distinct substrate specificity and is not applicable to this restricticin-cluster protein. Although a model lacking database access might struggle to distinguish B from C, the annotation is unambiguous."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0083",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry P0DXV3 (RESC_ASPSL, Nonribosomal peptide synthetase resC / Restricticin biosynthesis cluster protein C) carries the PATHWAY annotation 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence from PubMed:39105744, a 2024 J. Agric. Food Chem. paper confirming function, catalytic activity, and pathway). The sequence matches exactly (SHA-256 confirmed). The expected answer B is directly and experimentally supported.",
    "evidence_ids": ["C5", "C6", "H3", "H2", "C4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A knowledgeable model could identify the protein as a nonribosomal peptide synthetase (NRPS) from domain signatures (condensation, adenylation, and thiolation motifs visible in the ~1295-aa sequence), which eliminates options A (threonine synthase) and D (oxylipin/lipoxygenase pathway) since those involve entirely different enzyme classes. However, distinguishing B (Antifungal biosynthesis) from C (ergot alkaloid biosynthesis) requires knowing which specific secondary metabolite this particular NRPS assembles. Both are fungal NRPS-associated pathways, and the sequence does not contain a generalizable signature that uniquely maps to 'antifungal' rather than 'ergot alkaloid' biosynthesis.",
    "missing_item_specific_fact": "The identity of the compound synthesized by this specific NRPS (restricticin) and its classification as an antifungal agent. This requires either exact sequence-to-database matching (UniProt P0DXV3) or memorization of the restricticin biosynthetic cluster literature (PubMed:39105744). Without this item-specific annotation, the B-vs-C distinction cannot be resolved by general biological reasoning about NRPS enzymes.",
    "reason": "While NRPS identification from domain architecture is feasible, the pathway assignment among plausible fungal secondary-metabolite options (B vs C) depends on knowing the specific biosynthetic product. No general NRPS feature distinguishes antifungal peptide biosynthesis from ergot alkaloid biosynthesis at the sequence level without database lookup."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and D are clearly eliminable for an NRPS enzyme. Between B and C, the UniProt annotation with experimental evidence definitively assigns 'Antifungal biosynthesis.' Ergot alkaloid biosynthesis involves a different NRPS (EasC) with distinct substrate specificity and is not applicable to this restricticin-cluster protein. Although a model lacking database access might struggle to distinguish B from C, the annotation is unambiguous."
  },
  "important_caveats": [
    "The UniProt entry was first released in 2025-02-05 (entry version 1) and the pathway annotation was added with experimental evidence from a 2024 publication. The benchmark construction date relative to this entry's availability is unknown.",
    "The 'Antifungal biosynthesis' pathway label is a UniProt-curated category; the underlying compound (restricticin) is described in the source paper as having 'phytotoxic activity,' and the antifungal classification comes from the UniProt curation team's pathway assignment.",
    "The sequence is 1295 aa, consistent with a single-module NRPS (C-A-T architecture), which is a necessary but not sufficient clue for pathway identification."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The matched UniProt record annotates this protein's pathway as “Antifungal biosynthesis,” citing experimental evidence (ECO:0000269). The cited publication concerns discovery and heterologous expression of the associated molecule, though the underlying study was not independently reviewed here.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The long sequence is consistent with a nonribosomal peptide synthetase, which supports specialized-metabolite biosynthesis and makes the threonine and oxylipin options less compelling. But NRPS architecture alone does not distinguish antifungal biosynthesis from ergot alkaloid biosynthesis; either pathway can involve specialized fungal biosynthetic enzymes.


**Missing item-specific fact**

> The protein's association with the particular biosynthetic cluster or product pathway is needed to distinguish antifungal biosynthesis from ergot alkaloid biosynthesis.


**Reason**

> Transferable enzyme-family knowledge supports a broad secondary-metabolism inference, but does not meaningfully select between the two offered specialized fungal pathways. Choosing B requires pathway-specific knowledge about this protein beyond the sequence features identified here.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "B",
  "C"
]
```

> The sequence's apparent NRPS character is compatible with specialized fungal metabolite pathways, but the choices provide no sequence-linked clue that separates antifungal biosynthesis from ergot alkaloid biosynthesis.


### Important caveats

- The source record's sequence matches the supplied sequence; its pathway annotation cites experimental evidence, but that evidence was not independently validated here.
- The protein identity, organism, and source annotation are reviewer-only information and are not used as original-input clues for answerability.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The long sequence is consistent with a nonribosomal peptide synthetase, which supports specialized-metabolite biosynthesis and makes the threonine and oxylipin options less compelling. But NRPS architecture alone does not distinguish antifungal biosynthesis from ergot alkaloid biosynthesis; either pathway can involve specialized fungal biosynthetic enzymes.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's association with the particular biosynthetic cluster or product pathway is needed to distinguish antifungal biosynthesis from ergot alkaloid biosynthesis.",
    "reason": "Transferable enzyme-family knowledge supports a broad secondary-metabolism inference, but does not meaningfully select between the two offered specialized fungal pathways. Choosing B requires pathway-specific knowledge about this protein beyond the sequence features identified here."
  },
  "case_id": "pathway_0083",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The matched UniProt record annotates this protein's pathway as “Antifungal biosynthesis,” citing experimental evidence (ECO:0000269). The cited publication concerns discovery and heterologous expression of the associated molecule, though the underlying study was not independently reviewed here."
  },
  "important_caveats": [
    "The source record's sequence matches the supplied sequence; its pathway annotation cites experimental evidence, but that evidence was not independently validated here.",
    "The protein identity, organism, and source annotation are reviewer-only information and are not used as original-input clues for answerability."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "B",
      "C"
    ],
    "reason": "The sequence's apparent NRPS character is compatible with specialized fungal metabolite pathways, but the choices provide no sequence-linked clue that separates antifungal biosynthesis from ergot alkaloid biosynthesis."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0083",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The matched UniProt record annotates this protein's pathway as “Antifungal biosynthesis,” citing experimental evidence (ECO:0000269). The cited publication concerns discovery and heterologous expression of the associated molecule, though the underlying study was not independently reviewed here.",
    "evidence_ids": ["C5", "C6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The long sequence is consistent with a nonribosomal peptide synthetase, which supports specialized-metabolite biosynthesis and makes the threonine and oxylipin options less compelling. But NRPS architecture alone does not distinguish antifungal biosynthesis from ergot alkaloid biosynthesis; either pathway can involve specialized fungal biosynthetic enzymes.",
    "missing_item_specific_fact": "The protein's association with the particular biosynthetic cluster or product pathway is needed to distinguish antifungal biosynthesis from ergot alkaloid biosynthesis.",
    "reason": "Transferable enzyme-family knowledge supports a broad secondary-metabolism inference, but does not meaningfully select between the two offered specialized fungal pathways. Choosing B requires pathway-specific knowledge about this protein beyond the sequence features identified here."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["B", "C"],
    "reason": "The sequence's apparent NRPS character is compatible with specialized fungal metabolite pathways, but the choices provide no sequence-linked clue that separates antifungal biosynthesis from ergot alkaloid biosynthesis."
  },
  "important_caveats": [
    "The source record's sequence matches the supplied sequence; its pathway annotation cites experimental evidence, but that evidence was not independently validated here.",
    "The protein identity, organism, and source annotation are reviewer-only information and are not used as original-input clues for answerability."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** output error.
**Canonical saved status:** `invalid_review`.

**This saved response has an output error and is not a usable structured review.** Any labels below remain the original saved values; they are excluded from label distributions and agreement. This output status does not judge the benchmark question, author key or biological correctness. No field or option ID has been repaired.

No visible final review text was saved. Internal model reasoning is not a substitute for a visible review and is not published. The final-content extraction failed because the saved final content was not text.

**Saved parsed visible review:** `null`.

**Exact saved visible final text:** empty string (`""`). No visible final is synthesized from private reasoning.

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "P0DXV3",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "8888a1267f18d290e93491ffcb6a6b64bd5608d69c9b883c8185caad7ba8dc3f",
  "benchmark_sequence_length": 1295,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 6,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "19a0760299ea86767aedd0c4bc7a4c03cea71f9b30a199fbad0f1273b220873a",
  "current_source_sequence_sha256": "8888a1267f18d290e93491ffcb6a6b64bd5608d69c9b883c8185caad7ba8dc3f",
  "current_source_sequence_length": 1295,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 4,
  "selected_historical_version": {
    "accession": "P0DXV3",
    "database": "Swiss-Prot",
    "entryVersion": 4,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "RESC_ASPSL",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "1b7003df6665300ef1ac888ec6d64f0457b8f53c5d0454d1efab44d4b6ba307d",
  "selected_historical_source_sequence_sha256": "8888a1267f18d290e93491ffcb6a6b64bd5608d69c9b883c8185caad7ba8dc3f",
  "selected_historical_source_sequence_length": 1295,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 4,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV3.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV3.json",
  "source_sha256": "19a0760299ea86767aedd0c4bc7a4c03cea71f9b30a199fbad0f1273b220873a",
  "retrieved_utc": "2026-11-02T04:29:45.732991+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"P0DXV3\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV3.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV3.json",
  "source_sha256": "19a0760299ea86767aedd0c4bc7a4c03cea71f9b30a199fbad0f1273b220873a",
  "retrieved_utc": "2026-11-02T04:29:45.732991+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":6,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV3.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV3.json",
  "source_sha256": "19a0760299ea86767aedd0c4bc7a4c03cea71f9b30a199fbad0f1273b220873a",
  "retrieved_utc": "2026-11-02T04:29:45.732991+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Eurotiomycetes\",\"Eurotiomycetidae\",\"Eurotiales\",\"Aspergillaceae\",\"Aspergillus\",\"Circumdati\"],\"scientificName\":\"Aspergillus sclerotiorum\",\"taxonId\":138282}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV3.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV3.json",
  "source_sha256": "19a0760299ea86767aedd0c4bc7a4c03cea71f9b30a199fbad0f1273b220873a",
  "retrieved_utc": "2026-11-02T04:29:45.732991+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Restricticin biosynthesis cluster protein C\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"6.3.2.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Nonribosomal peptide synthetase resC\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV3.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV3.json",
  "source_sha256": "19a0760299ea86767aedd0c4bc7a4c03cea71f9b30a199fbad0f1273b220873a",
  "retrieved_utc": "2026-11-02T04:29:45.732991+00:00",
  "json_pointer": "/comments/3",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV3.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV3.json",
  "source_sha256": "19a0760299ea86767aedd0c4bc7a4c03cea71f9b30a199fbad0f1273b220873a",
  "retrieved_utc": "2026-11-02T04:29:45.732991+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Lu Y.\",\"Li Y.\",\"Dou M.\",\"Liu D.\",\"Lin W.\",\"Fan A.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"39105744\"},{\"database\":\"DOI\",\"id\":\"10.1021/acs.jafc.4c04244\"}],\"citationType\":\"journal article\",\"firstPage\":\"18520\",\"id\":\"39105744\",\"journal\":\"J. Agric. Food Chem.\",\"lastPage\":\"18527\",\"publicationDate\":\"2024\",\"title\":\"Discovery of a hybrid molecule with phytotoxic activity by genome mining, heterologous expression, and OSMAC strategy.\",\"volume\":\"72\"},\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV3?format=txt&versions=4)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV3?format=txt&versions=4",
  "source_sha256": "1b7003df6665300ef1ac888ec6d64f0457b8f53c5d0454d1efab44d4b6ba307d",
  "retrieved_utc": "2026-11-02T04:29:53.747402+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   RESC_ASPSL              Reviewed;        1295 AA.\nAC   P0DXV3;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 1.\nDT   28-JAN-2026, entry version 4.\nDE   RecName: Full=Nonribosomal peptide synthetase resC {ECO:0000303|PubMed:39105744};\nDE            EC=6.3.2.- {ECO:0000305|PubMed:39105744};\nDE   AltName: Full=Restricticin biosynthesis cluster protein C {ECO:0000303|PubMed:39105744};\nGN   Name=resC {ECO:0000303|PubMed:39105744};\nOS   Aspergillus sclerotiorum.\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;\nOC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;\nOC   Aspergillus subgen. Circumdati.\nOX   NCBI_TaxID=138282;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV3?format=txt&versions=4)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV3?format=txt&versions=4",
  "source_sha256": "1b7003df6665300ef1ac888ec6d64f0457b8f53c5d0454d1efab44d4b6ba307d",
  "retrieved_utc": "2026-11-02T04:29:53.747402+00:00",
  "source_locator": "lines 15-22",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND\nRP   PATHWAY.\nRX   PubMed=39105744; DOI=10.1021/acs.jafc.4c04244;\nRA   Lu Y., Li Y., Dou M., Liu D., Lin W., Fan A.;\nRT   \"Discovery of a hybrid molecule with phytotoxic activity by genome mining,\nRT   heterologous expression, and OSMAC strategy.\";\nRL   J. Agric. Food Chem. 72:18520-18527(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV3?format=txt&versions=4)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/P0DXV3?format=txt&versions=4",
  "source_sha256": "1b7003df6665300ef1ac888ec6d64f0457b8f53c5d0454d1efab44d4b6ba307d",
  "retrieved_utc": "2026-11-02T04:29:53.747402+00:00",
  "source_locator": "lines 52-52",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:39105744}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 4,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 83. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
